Serologic Testing for Middle East Respiratory Syndrome Coronavirus and SARS-CoV-2 Cross-Reactive Immune Responses, the Netherlands.

Te Marvelde MR, Mykytyn AZ, Raadsen MP, Bouffier AHJ, Varela SB, de Vries RD, GeurtsvanKessel CH, Haagmans BL

Open source

DOI
10.3201/eid3211.260690
Published
2026 Nov
Container
Emerging infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3201/eid3211.260690,
  title = {Serologic Testing for Middle East Respiratory Syndrome Coronavirus and SARS-CoV-2 Cross-Reactive Immune Responses, the Netherlands.},
  author = {Te Marvelde MR and Mykytyn AZ and Raadsen MP and Bouffier AHJ and Varela SB and de Vries RD and GeurtsvanKessel CH and Haagmans BL},
  year = {2026},
  journal = {Emerging infectious diseases},
  doi = {10.3201/eid3211.260690},
  url = {https://doi.org/10.3201/eid3211.260690}
}

RIS

TY  - JOUR
TI  - Serologic Testing for Middle East Respiratory Syndrome Coronavirus and SARS-CoV-2 Cross-Reactive Immune Responses, the Netherlands.
AU  - Te Marvelde MR
AU  - Mykytyn AZ
AU  - Raadsen MP
AU  - Bouffier AHJ
AU  - Varela SB
AU  - de Vries RD
AU  - GeurtsvanKessel CH
AU  - Haagmans BL
PY  - 2026
JO  - Emerging infectious diseases
DO  - 10.3201/eid3211.260690
UR  - https://doi.org/10.3201/eid3211.260690
ER  - 

APA

MR, T. M., AZ, M., MP, R., AHJ, B., SB, V., RD, D. V., CH, G., & BL, H. (2026). Serologic Testing for Middle East Respiratory Syndrome Coronavirus and SARS-CoV-2 Cross-Reactive Immune Responses, the Netherlands.. Emerging infectious diseases. https://doi.org/10.3201/eid3211.260690

Source records